Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This Week in Biotech
Motley Fool
Sunday, April 28, 2013 - 12:13pm
tags:
Avanir, Medivation, Pfizer, Achillion, Theravance, Gilead Sciences, GSK
Growth Opportunities but Uncertainty Around Core Drug
Motley Fool
Sunday, April 28, 2013 - 12:11pm
tags:
Spectrum Pharmaceuticals, Fusilev
TG Therapeutic: A Small-Cap Biotech With Great Potential Growth
Seeking Alpha
Sunday, April 28, 2013 - 12:09pm
tags:
TG Therapeutics
Regenerative Medicine's Time Has Come
Seeking Alpha
Sunday, April 28, 2013 - 12:09pm
tags:
regenerative medicine, NeoStem, Neuralstem
Exciting Catalysts Approaching for This Bet
Motley Fool
Sunday, April 28, 2013 - 12:07pm
tags:
obesity, weight loss, Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Qsymia
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
Yahoo/BusinessWire
Sunday, April 28, 2013 - 12:05pm
tags:
Prolor Biotech, lawsuits
Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Bloomberg
Sunday, April 28, 2013 - 12:04pm
tags:
Gilead Sciences, Bristol-Myers Squibb, hepatitis C, hepatitis, sofosbuvir, daclatasvir
Did Novartis Violate Its Corporate Integrity Agreement?
Forbes
Saturday, April 27, 2013 - 11:06am
tags:
Novartis, legal
Valeant Pharmaceuticals in Talks to Buy Actavis
Wall Street Journal
Saturday, April 27, 2013 - 11:05am
tags:
Valeant Pharmaceuticals, Actavis, M&A
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, April 27, 2013 - 11:00am
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
Covidien reports smaller profit for second quarter
The Post Star, NY
Saturday, April 27, 2013 - 10:59am
tags:
Covidien, earnings
Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall Street Cheat Street
Saturday, April 27, 2013 - 10:10am
tags:
Aegerion, earnings
Merck's Product Pipeline Could Lead To Healthy Shareholder Returns
Motley Fool
Saturday, April 27, 2013 - 10:10am
tags:
Merck
Earnings Preview: Pfizer to report Q1 results
Yahoo/AP
Saturday, April 27, 2013 - 10:09am
tags:
Pfizer, earnings
Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue
Seeking Alpha
Saturday, April 27, 2013 - 10:08am
tags:
Bristol-Myers Squibb
U.S. Files Suit Accusing Novartis of Paying Kickbacks to Doctors
Fox Business News
Saturday, April 27, 2013 - 10:07am
tags:
Novartis, kickbacks, legal
4 Stocks Improving Performance Of The Health Care Sector
The Street
Saturday, April 27, 2013 - 10:02am
tags:
Watson Pharmaceuticals, Actavis, AstraZeneca, Merck
Anacor Prices New Stock Offering
Motley Fool
Saturday, April 27, 2013 - 10:00am
tags:
Anacor
Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID
Yahoo/PR Newswire
Saturday, April 27, 2013 - 9:59am
tags:
Cempra, Solithromycin
Teva's 3 Biggest Challenges
Motley Fool
Saturday, April 27, 2013 - 9:58am
tags:
Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.